▶ Watch Video: Abbott recalls some infant formula after reports of illnesses

Abbott has issued a recall for another lot of baby formula after an additional child who is believed to have consumed the formula fell ill and later died, the FDA said Monday. The recall affects one lot of Similac PM 60/40 that was made at Abbott Nutrition’s Sturgis, Michigan, facility. 

Parents should check any purchased formula for the lot code # 27032K80 (can) or # 27032K800 (case) and throw it away if it matches, the FDA said. Consumers can also use this link to check if they should throw away their formula. 

The FDA said this lot is a special formula “for certain infants who would benefit from lowered mineral intake.” It was not included in the previous recall. 

“At this time, Similac PM 60/40 with lot code 27032K80 (can) / 27032K800 (case) are the only type and lots of this specialty formula being recalled,” the FDA said. 

The recall comes after the CDC announced that another infant who had been exposed to the formula was infected with Cronobacter sakazakii. The FDA said the Cronobacter infection “may have been a contributing cause of death.” That infant was believed to have consumed product from the lot that is being recalled, the FDA said. 

The recall also comes only 9 days after the company recalled multiple formulas made at the same Abbot facility, including Similac, Alimentum and EleCare. Parents are encouraged to check their formulas, as exposure to Cronobacter can cause sepsis and meningitis. Infants displaying symptoms of poor feeding, irritability, or fevers should receive immediate care. 

In total, four infants have reported Cronobacter infections and one has reported a Salmonella Newport infection, according to the FDA. All five infants were hospitalized and two died, the FDA said. 

Baby formula is offered for sale at a big box store on January 13, 2022 in Chicago, Illinois. 

Getty Images

“We understand that infant formula is the sole source of nutrition for many infants and is an essential product,” the FDA said in an advisory Monday. “FDA is working with Abbott Nutrition to better assess the impacts of the recall and understand production capacity at other Abbott facilities that produce some of the impacted brands. We are also working with Abbott Nutrition on safe resumption of production at the Sturgis, MI facility.”